COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
- PMID: 33034579
- DOI: 10.5543/tkda.2020.64072
COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
Similar articles
-
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].Pneumologie. 2020 Sep;74(9):611-614. doi: 10.1055/a-1165-6994. Epub 2020 Sep 11. Pneumologie. 2020. PMID: 32916743 German. No abstract available.
-
COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?J Intern Med. 2020 Oct;288(4):410-421. doi: 10.1111/joim.13101. Epub 2020 Jun 8. J Intern Med. 2020. PMID: 32459372 Free PMC article. Review.
-
SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.Infect Disord Drug Targets. 2020;20(3):348-349. doi: 10.2174/1871526520999200505174704. Infect Disord Drug Targets. 2020. PMID: 32370727 No abstract available.
-
Drugs and the renin-angiotensin system in covid-19.BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313. BMJ. 2020. PMID: 32241880 No abstract available.
-
The renin-angiotensin system - a therapeutic target in COVID-19?Clin Med (Lond). 2020 Jul;20(4):e72-e75. doi: 10.7861/clinmed.2020-0146. Epub 2020 May 15. Clin Med (Lond). 2020. PMID: 32414711 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical